Anita Nelson, MD, discusses the FDA's approval extending etonogestrel implant use to 5 years and the new REMS certification clinicians must complete by February 23, 2027.
Related to this article
A real-world study presented at Psych Congress found that zuranolone's PPD symptom improvements were sustained through day 90.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
FDA accepted for review an sNDA for MIUDELLA copper IUD for a 6-year duration, with a PDUFA date in Q2 2027.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Atogepant reduced perimenstrual migraine days vs. placebo and met all 8 secondary endpoints in the Phase 3 LUNA study.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Sameena Rahman, MD, on bias, dismissed diagnoses, and the vulvar vestibule
2
CD38 is tied to age-related placental NAD+ decline in preclinical study
3
Hugh Taylor, MD, discusses first- and second-line medical therapy for endometriosis
4
PMOS Awareness Month: Watch our expert panel discussion on PMOS
5